MCL1 and breast cancer: Despite indifference to loss or inhibition of MCL-1 in 2D culture, the impact of targeting MCL-1 in a tumoursphere assay was dramatic that suggests that the biological relevance of targeting MCL-1 in vivo may be underestimated by interpretation of human breast cancer cell line 2D culture [9, 12, 34].